Accuray (Nasdaq:ARAY) this week announced that it has appointed Franco Palomba as VP, chief accounting officer and controller.
Palomba will be responsible for the controllership functions at the Sunnyvale, California-based company, which includes global accounting organization and associated budgetary and administrative operations and financial and regulatory compliance. He will report directly to senior VP and CFO Ali Pervaiz.
“Franco is a well-rounded executive with the deep strategic and tactical expertise necessary to help advance our global finance organization and drive the growth of our business. Under his guidance his teams have delivered significant value including streamlining processes, reducing debt and increasing income. We look forward to his leadership at this important time in our organization’s evolution,” Pervaiz said in a news release.
Prior to joining the company, Palomba was the VP of finance and controller at Ashvattha Therapeutics where he was responsible for all internal and external resources. He has more than 30 years of accounting and finance expertise and has held leadership roles at Varian Medical Systems (now a part of Siemens Healthineers), Genomic Health, Varian and Pricewaterhouse Coopers.
“The opportunity with Accuray will enable me to re-engage in the radiation therapy industry, an area of particular interest and importance to me. I’ve always been impressed by the innovation behind the organization’s technology and the team’s dedication to improving the lives of patients who would benefit from radiation treatments,” Palomba said. “I’m looking forward to partnering with the global team to help accelerate the company’s growth and build shareholder value.”